Atlanta, GA, United States of America

Jennifer M Munson

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Jennifer M Munson

Introduction

Jennifer M Munson is a prominent inventor based in Atlanta, GA (US). She has made significant contributions to the field of medical technology, particularly in cancer treatment. With a total of 2 patents, her work focuses on innovative therapies that target invasive tumors.

Latest Patents

One of her latest patents involves nanocarrier therapy for treating invasive tumors. This technology utilizes liposomes of a size less than 200 nanometers to target tumors and preferentially deliver imipramine blue. This compound is effective in decreasing the invasiveness of tumors and inhibiting tumor metastasis, including in brain tumors such as gliomas. The liposomes are composed of cholesterol and chemically pure phospholipids that are essentially neutral, containing saturated fatty acids of between 16 and 18 carbon atoms, such as distearoylphosphatidyl choline. Additionally, they can include one or more pegylated phospholipids, such as DSPE-PEG.

Career Highlights

Jennifer has worked with notable institutions such as Emory University and Georgia Tech Research Corporation. Her research has been pivotal in advancing therapeutic strategies for cancer treatment.

Collaborations

Some of her notable coworkers include Ravi Bellamkonda and Jack Arbiser. Their collaborative efforts have contributed to the success of her innovative projects.

Conclusion

Jennifer M Munson's work exemplifies the impact of innovation in medical technology, particularly in the fight against cancer. Her patents and collaborations highlight her commitment to improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…